B cells, some cells of the monocyte/macrophage lineage and certain neurons in the brain exhibit constitutive nuclear We have isolated a human cDNA which encodes a NF-κB activity). novel IκB family member using a yeast two-hybrid
The IκB proteins also comprise a distinct family (Haskill screen for proteins able to interact with the p52 subunit et al., 1991; Beg and Baldwin, 1993 ; Gilmore and Morin, of the transcription factor NF-κB. The protein is found 1993; Thompson et al., 1995) : IκB-α and IκB-β, which in many cell types and its expression is up-regulated are cytoplasmic in localization and inhibit both DNA following NF-κB activation and during myelopoiesis.
binding and transactivation; and the product of the bcl-3 Consistent with its proposed role as an IκB molecule, proto-oncogene, which is nuclear and can either inhibit IκB-ε is able to inhibit NF-κB-directed transactivation DNA binding or superactivate transcription via NF-κB, via cytoplasmic retention of rel proteins. IκB-ε transladependent upon the type of NF-κB complexes involved tion initiates from an internal ATG codon to give rise (Wulczyn et al., 1992; Bours et al., 1993; , to a protein of 45 kDa, which exists as multiple . These inhibitors all contain phosphorylated isoforms in resting cells. Unlike the multiple copies of a motif, the ankyrin repeat, which other inhibitors, it is found almost exclusively in cominteracts with the RHD of the the rel/NF-κB proteins. In plexes containing RelA and/or cRel. Upon activation, addition, the C-terminal portions of the p105 and p100 IκB-ε protein is degraded with slow kinetics by a precursors of the p50 and p52 subunits of NF-κB also proteasome-dependent mechanism. Similarly to IκB-α contain ankyrin repeats and these precursors have also and IκB-β, IκB-ε contains multiple ankyrin repeats been shown to behave as IκB proteins (Capobianco et al., and two conserved serines which are necessary for 1992; Rice et al., 1992; Mercurio et al., 1993 ; Naumann signal-induced degradation of the molecule. A unique et al., 1993a,b; Scheinman et al., 1993 ; Sif and Gilmore, lysine residue located N-terminal of the serines appears 1993; Sun et al., 1994) . Furthermore, it has been demonto be not strictly required for degradation. Unlike IκB-strated that proteins corresponding to the C-terminal, α and IκB-β, IκB-ε does not contain a C-terminal ankyrin repeat-containing portions of p105 and p100 can PEST-like sequence. IκB-ε would, therefore, appear to be found in certain cell types and act as IκB molecules regulate a late, transient activation of a subset of genes, (IκB-γ and IκB-δ respectively; Inoue et al., 1992; Dobrzan 
Introduction
Treatment of cells with different inducers [including phorbol 12-myristate-13-acetate (PMA), tumour necrosis NF-κB is a multi-subunit transcription factor that is factor (TNF), IL-1, lipopolysaccharide (LPS), viral infecinvolved in the regulation of a large number of genes that tion and many mitogens and cytokines] results in the control various aspects of the immune and inflammatory liberation of active NF-κB and its subsequent translocation response [MHC class I genes, immunoglobulin κ light to the nucleus, there to activate transcription of its target chain, interleukin 2 (IL-2) and its receptor,  genes. In the case of IκB-α, this inactivation of the inhibitor granulocyte-macrophage colony-stimulating factor (GMis a result of rapid phosphorylation and degradation of CSF), β-interferon, T-cell receptor β chain] as well as of the IκB molecule (for a review, see Finco and Baldwin, several viruses, including HIV-1 (for a review, see Baeuerle 1995; Israël, 1995; Thanos and Maniatis, 1995; Verma and Henkel, 1994; Siebenlist et al., 1994; Finco and et al., 1995) . Studies have demonstrated that treatment Baldwin, 1995; Thanos and Maniatis, 1995; Verma et al., with various stimuli leads to phosphorylation on two 1995). In mammalian cells, NF-κB activity contains homocritical serine residues  Brown and heterodimers of the rel/NF-κB family of proteins (p50 and p52, synthesized as p105 and p100 precursors et al., 1995; Chen et al., 1995; Traenckner et al., 1995; Whiteside et al., 1995; Didonato et al., 1996; Sun et al., family. We have called this new protein IκB-ε. The two other cDNAs isolated during this screening will be 1996). This process renders the molecule a substrate for ubiquitination upon, amongst others, two lysines in the described elsewhere. Northern blot analysis indicated that IκB-ε is encoded N-terminus, thus targeting the molecule for degradation by the ubiquitin-26S proteasome pathway (Alkalay et al., by an mRNA of 2.2 kb (Figure 3) found in all cells thus far tested. The cDNA isolated from the two-hybrid screen 1995; Chen et al., 1995; Baldi et al., 1996) . This degradation is dependent upon C-terminal was used to probe a cDNA library prepared from human fetal brain, and multiple clones were obtained. Two PEST sequences (Whiteside et al., 1995) . The IκB-β protein is also degraded following stimulation, with overlapping cDNAs were found to contain the complete ORF for IκB-ε. kinetics that vary between cell types but which are slower than found for IκB-α (Thompson et al., 1995; R.Weil and A.Israël, unpublished results) . The presence of correspondStructure of IκB-ε The primary sequence revealed an ORF of 500 amino ing serine and lysine residues in the N-terminus, and a C-terminal PEST-like region have led to the suggestion acids encoding a protein with a predicted M r of 55 kDa ( Figure 1A ) and which gives rise to a protein of 62 kDa that degradation of IκB-β is controlled by a similar mechanism. Indeed, it has been demonstrated recently that when expressed in vitro or in cells (data not shown). The ORF encodes the entire fragment isolated from the twomutation of the two serine residues to alanines inhibits the degradation of IκB-β in response to extracellular hybrid screen. Unlike the classical IκB-α and IκB-β, IκB-ε contains signalling and to intracellular Tax protein (Didonato et al., 1996; McKinsey et al., 1996; R.Weil and A.Israël, unpub- a long N-terminal extension that includes a region rich in G residues, reminiscent of the region of p105 responsible lished results).
By screening a human PBL-derived cDNA library using for processing (Lin and Ghosh, 1996) . This region contains homology to a half-active site of the trypsin family of the yeast two-hybrid system for proteins able to interact with the p52 subunit of NF-κB, we have isolated a cDNA proteases (GDSG, amino acids 24-27), although the other half-site is not apparent. The relevance of this observation that encodes a novel IκB family member, which we have designated I kappa B epsilon (IκB-ε). Although the is unclear. However, closer inspection of the nucleotide sequence revealed that the first methionine in the ORF is cDNA contains an open reading frame (ORF) capable of producing a 62 kDa protein, translation is initiated at a not in a sequence context conducive for efficient translation, most noticeably the presence of a pyrimidine residue second methionine to form a 45 kDa protein which exists as multiple phosphorylated isoforms in resting cells.
at position -3 ( Figure 1B , IκB-ε MET1; Kozak, 1992) . Further analysis of the ORF of IκB-ε revealed the presence Sequence analysis of the cDNA reveals that IκB-ε protein strongly resembles other members of the IκB family: it of a second, in-frame ATG codon at position 140; this methionine is situated in a favourable sequence context contains six, closely spaced ankyrin repeats and two serine residues (at positions 18 and 22 after the second for efficient initiation of translation ( Figure 1B , IκB-ε MET140). Since we have found no evidence of a 62 kDa methionine) in a sequence context highly similar to those found around the serines of IκB-α and IκB-β necessary protein in cells, nor any to support a model in which the larger protein acts as a precursor of the 45 kDa protein for ligand-induced degradation. It also contains a unique N-terminally located lysine (at position 6 after the second which co-precipitates with rel proteins (see below and Discussion), we propose that the scanning ribosome skips methionine), but has no PEST-like sequence in the C-terminal region. Unlike IκB-α, IκB-ε is found comover the first ATG codon and initiates translation at Met140. In support of this hypothesis, cDNAs which plexed predominantly with RelA and cRel in resting cells, and may thus control the expression of a distinct subset initiate translation at this methionine when translated in vitro or when expressed in transfected 70Z/3 cells give of NF-κB-regulated genes. Upon stimulation with PMA or LPS, IκB-ε is proteolytically degraded via a mechanism rise to proteins with a mol. wt of 45 kDa which comigrate with the protein found bound to NF-κB complexes which is sensitive to antioxidants and inhibitors of proteasome activity. This degradation is preceded by a shift (see below and data not shown). IκB-ε contains six consecutive ankyrin repeats, whose in electrophoretic mobility and is dependent upon the two N-terminal serine residues, but not upon Lys6.
sequences closely resemble those found in other IκB proteins; the similarity between ankyrin repeats in the same position is greater than the similarity between
Results
different repeats in the same molecule ( Figure 1C ). It has been shown for IκB-α that its degradation is dependent Isolation of IκB-ε cDNA To search for novel proteins capable of interacting with upon phosphorylation on two serine residues situated N-terminally to the ankyrin repeats, and subsequent ubiqui-NF-κB, we performed a yeast two-hybrid screen using the p52 subunit of NF-κB as bait. From 400 000 independtination upon two lysine residues situated 10 amino acids N-terminally to the serines (Alkalay et al., 1995 ; Brockman ent clones tested, 185 colonies grew on selective medium and turned blue when tested in filter lift assay. After reet al., 1995; Brown et al., 1995; Chen et al., 1995; Traenckner et al., 1995; Whiteside et al., screening , five of these were found to contain cDNAs which specifically interacted with the bait. Primary 1995; Baldi et al., 1996; Didonato et al., 1996; Sun et al., 1996) . Similar sequences have been found in IκB-β and, sequence analysis revealed these clones to encode three independent cDNAs. One of these was found to contain at least in the case of the serines, play a similar role in the regulation of its degradation in response to extracellular multiple repetitions of the ankyrin repeat sequence motif, highly related to those found in members of the IκB stimuli (Didonato et al., 1996; McKinsey et al., 1996) . (Grunert and Jackson, 1994; Kozak, 1995 IκB-ε also contains a pair of serines, in a similar sequence 146-164, 167-190 and 208-236, PESTFIND software, Rodgers et al., 1986) . context to that found in IκB-α and IκB-β, preceded N-terminally by a lysine residue (Lys145, Figure 1D ). In addition, IκB-α and IκB-β contain C-terminal regions rich IκB-ε inhibits transactivation by NF-κB To investigate whether the IκB-ε could inhibit transactivin P, E, D, S and T residues, sequences implicated in the rapid turnover of proteins (Rodgers et al., 1986) . Indeed, ation by NF-κB in vivo, cDNAs encoding IκB proteins were co-transfected with a κB-dependent luciferase this region is essential for IκB-α (Brown et al., 1995; Rodriguez et al., 1995; Whiteside et al., 1995) and IκB-β reporter gene into Jurkat cells which subsequently were stimulated with either PMA and ionomycin (PMA/iono, (R. Weil and A.Israël, unpublished results) to be degraded in response to extracellular stimuli. Such a region is absent Figure 2A ) or TNF (data not shown). Levels of overexpressed IκB proteins are such that cells are unable to in IκB-ε, although putative PEST regions are to be found in the region N-terminal to the ankyrin repeats (amino acids degrade all the exogenous IκB present, resulting in an teins. Studies in HeLa cells on the subcellular localization of transfected rel proteins in the absence or presence of co-transfected IκB-ε demonstrate that IκB-ε, like IκB-α and IκB-β, acts to retain rel proteins in the cytoplasm (data not shown).
IκB-ε mRNA is up-regulated following NF-κB analysed IκB-ε expression by Northern blot (Figure 3 ). The expression of IκB-ε mRNA is strongly up-regulated following 2 h of stimulation, suggesting a second, slower, inhibition of induced transcription (data not shown). In the absence of co-transfected IκB protein, PMA/iono negative feedback loop for tightly controlling NF-κB activity. We also studied the expression of the IκB-ε gene strongly transactivated the reporter gene (compare lanes 1 and 2). Co-transfection with IκB-α (lane 3), IκB-β (lane during the differentiation of HL-60 cells into macrophages or granulocytes. Following differentiation into granulo-4) and both forms of IκB-ε (lanes 5 and 6) resulted in strong inhibition of transactivation. In similar experiments cytes (lane 5) or macrophages (lane 6), we observed a strong induction in the expression of the IκB-ε mRNA. using a co-transfected RelA-expressing plasmid as an activator ( Figure 2B ), it was clear that both forms of IκB-ε could also inhibit RelA-activated transcription (lanes 6-IκB-ε protein exists as multiple, phosphorylated isoforms complexed predominantly to RelA and 11) at least as efficiently as IκB-α (lanes 3-5). Similar results have been obtained for the inhibition of cRelcRel proteins For IκB-ε to function as a bona fide inhibitory molecule, it activated transcription (data not shown). A constitutive promoter (HSV tk) was unaffected by expression of must be complexed to NF-κB molecules in resting cells. To demonstrate this, we precipitated different IκB-containing any IκB proteins (data not shown). These experiments demonstrate that IκB-ε can efficiently inhibit the transcomplexes from Jurkat, THP-1 and 70Z/3 cells and analysed associated proteins by Western blot with anti-cRel and antiactivation of the reporter gene by endogenous NF-κB induced with PMA/iono or by co-transfected RelA proRelA antisera. In Jurkat, THP-1 and 70Z/3 cells ( Figure 4A , lanes 3, 6 and 9 respectively), we found that both cRel cells, murine pre B cells, human monocytes, granulocytes and fibroblasts; see below and data not shown). In parallel and RelA could be co-precipitated with IκB-ε under native conditions. This precipitation was specific to the epitope experiments, we precipitated complexes containing IκB-α or IκB-β: interestingly, in THP-1 cells ( Figure 4A , lanes 4-used as no cRel nor RelA were precipitated when the antibody was blocked with an excess of its cognate peptide 6), the amount of cRel and RelA associated with IκB-ε is greater than that associated with either IκB-α or IκB-β (data not shown). We have found IκB-ε associated with NF-κB in all cell types thus far tested (human and mouse B (compare lane 6 with lanes 4 and 5), whereas in Jurkat cells (lanes 1-3) , the amounts of RelA and cRel precipitated by abolishes this resynthesis ( Figure 5A , upper panel, lanes 6-10), while CHX alone has no effect on IκB-ε protein IκB-β and IκB-ε are comparable, suggesting that IκB-ε is an important regulator of NF-κB activity in these cells. In levels, even after 2 h (lanes 11-14). In THP-1 cells ( Figure 5A , lower panel and Figure 5B ), treatment with both cases, very little RelA or cRel was precipitated by IκB-α. For all three IκB proteins, secondary precipitation of LPS also led to the disappearance of IκB-ε, with kinetics similar to those found for IκB-α and IκB-β ( Figure 5B ). the supernatant obtained after collection of the immune complexes was performed to verify that all IκB-containing Similar results were obtained in WEHI 231 cells stimulated with LPS (data not shown). Interestingly, after 30 min of complexes had been precipitated (data not shown). In contrast, a similar analysis in 70Z/3 cells (lanes 7-9) revealed treatment with LPS, a novel, more slowly migrating form of the protein was discernible ( Figure 5A , lower panel, that the majority of RelA (Ͼ90%) was associated with IκB-β. Both IκB-β and IκB-ε precipitated comparable quantities lanes 2 and 7 and B, upper panel, lane 2), suggestive of an inducible phosphorylation taking place before degradation. of cRel. Once again, IκB-α precipitated very little RelA or cRel. To analyse which other rel family proteins are After 4 h of treatment, IκB-ε levels re-increased in a CHX-sensitive manner ( Figure 5A , lower panel, compare associated with IκB-ε, we precipitated rel family proteins with specific anti-peptide antisera and looked for the preslanes 1-5 and 6-10).
Since the degradation of IκB-α and IκB-β in response ence of IκB-ε and IκB-α by Western blot assay. As shown in Figure 4B , antibodies raised against IκB-ε specifically to inducers of NF-κB activation has been shown to pass via the ubiquitin-26S proteasome pathway, we also tested precipitated a protein of 45 kDa from extracts of resting THP-1 cells (lanes 1 and 2). This protein was found in NFthe effects of an inhibitor of proteasome activity, N-acetylLeu-Leu-norleucinal (ALLN), upon IκB-ε degradation. κB complexes containing either RelA (lane 5) or cRel (lane 6), but not p50 or p52 (lanes 3 and 4). In contrast, IκB-α was Treatment with LPS/CHX for 2 h resulted in a complete disappearance of the protein in WEHI 231 ( Figure 6 , lane found predominantly associated with complexes containing p50 and RelA. IκB-ε proteins are detected more weakly 2) and THP-1 (human pre-monocyte cells, lane 8). In all cases, this degradation was inhibited by pre-treatment of than IκB-α because of the weaker reaction of the IκB-ε antisera than those raised against IκB-α (at least 50-fold, the cells with ALLN ( Figure 6 , lanes 3 and 6). Furthermore, the stabilized forms of IκB-ε present in extracts from cells our unpublished observations). We have obtained similar results using Jurkat or differentiated HL-60 cells (data not stimulated in the presence of ALLN migrated more slowly than those present in the extracts from untreated cells, shown). In control experiments, in vitro co-translation of rel and IκB-ε proteins demonstrated that all antibodies used further supporting the hypothesis that IκB-ε, like IκB-α, is inducibly phosphorylated in response to extracellular were able to interact efficiently with all IκB-ε/rel protein complexes (data not shown).
signals before being degraded (see below). During these studies, we noticed that IκB-ε is detectable as multiple isoforms in murine cells (Figures 4C and IκB-ε requires serines 157 and 161 to be degraded To study the domains of IκB-ε responsible for its ligand-6). One possibility is that the upper forms represent hyperphosphorylated forms of the lower protein. To test induced degradation, we constructed stable 70Z/3 cell lines expressing the 45 kDa form of IκB-ε. By precipitating this hypothesis, we precipitated cRel-containing complexes from WEHI 231 cells, and then treated the precipit-NF-κB complexes, we were able to show that, as is the case for THP-1 and Jurkat cells, the transfected IκB-ε was ated proteins with alkaline phosphatase. Proteins were then eluted with cognate peptide and analysed by SDSassociated predominantly with RelA-and cRel-containing complexes ( Figure 7 , compare lanes 4 and 5 with lanes 3 PAGE followed by Western blotting with an anti-IκB-ε antibody. As shown in Figure 4D , the upper forms of and 6). In addition, we assayed whether the exogenous protein was degraded in response to inducers of NF-κB IκB-ε associated with cRel disappear upon treatment with alkaline phosphatase (lane 2). It must be noted that the activity. As shown in Figure 8A , IκB-ε was degraded in response to treatment of cells with either PMA or LPS phosphorylated forms of the IκB-ε are much more readily detectable in WEHI 231 cells than in any of the human after 60 min of treatment. CHX was included in the induction protocol to avoid resynthesis of IκB-ε proteins cell lines used (see Figures 3-6) . The reason for this apparent discrepancy is, as yet, unclear.
as a result of induction of the cytomegalovirus (CMV) promoter used to drive expression of the transfected protein (data not shown). This inducible degradation could IκB-ε is proteolytically degraded in response to inducers of NF-κB activity be blocked by pre-treatment of cells with either ALLN ( Figure 8B, lane 7) or the anti-oxidant pyrollidine dithioSince IκB-ε has all the properties consistent with its function as a regulator of NF-κB activity, we went on to carbamate (PDTC) (lane 6). Identical results were obtained for cell lines expressing the 62 kDa form of the protein investigate whether IκB-ε activity was regulated during the induction of NF-κB. To this end, we prepared cytoplasmic (data not shown). We constructed stable cell lines expressing mutant IκB-ε extracts from Jurkat and THP-1 cells treated with PMA and ionomycin (PMA/iono) and bacterial LPS respectively, proteins and analysed the ability of the transfected proteins to be degraded in response to extracellular signalling in the presence or absence of cycloheximide (CHX). As shown in Figure 5A (upper panel), IκB-ε is degraded in events. We have shown that IκB-ε contains at its N-terminus two serine residues (Ser157 and Ser161, or Jurkat cells by PMA/iono with relatively slow kinetics (IκB-α is degraded after 15 min, data not shown) and Ser18 and Ser22 after the second methionine) in a sequence context highly similar to that found in IκB-α and IκB-β starts to be resynthesized after 2 h of treatment (lanes 1-5), in accordance with the results from Northern blotting ( Figure 1D ). We therefore mutated these two residues to alanines and analysed whether the mutated protein studies (Figure 3) . Induction in the presence of CHX 1 and 6) or treated with 50 ng/ml PMA plus 1 μg/ml ionomycin (lanes 2-5 and 7-10) in the absence (lanes 2-5) or presence (lanes 7-10) of 10 μg/ml CHX for the times indicated. Cells were also treated with 10 μg/ml CHX alone (lanes 11-14) for the times indicated. Extracts were boiled in 1% SDS, 0.5% β-mercaptoethanol, diluted 10-fold in TNT buffer and precipitated with anti-IκBε891. Immune complexes were precipitated, washed and then separated by SDS-PAGE. Proteins were blotted onto Immobilon and IκB-ε proteins revealed by Western blotting with IκBε891 antiserum. The positions of IκB-ε proteins are indicated. Lower panel: cytoplasmic extracts were prepared from 10 7 THP-1 cells either untreated (lanes 1 and 6) or treated with 1 μg/ml LPS (lanes 2-5 and 7-10) in the absence (lanes 2-5) or presence (lanes 7-10) of 10 μg/ml CHX for the times indicated. Cells were also treated with 10 μg/ml CHX alone (lanes 11-13) for the times indicated. IκB-ε proteins were revealed as described above. The positions of native (IκB-ε) and the more slowly migrating form of IκB-ε (IκB-ε*) are indicated. (B) Cytoplasmic extracts were prepared from 3ϫ10 6 THP-1 cells either untreated (lane 1) or treated with 1 μg/ml LPS (lanes 2-7) for the times indicated above the figure. Proteins were separated on SDS-PAGE and blotted for IκB-ε (IκB-ε891, upper panel), IκB-α (IκBαS5, middle associated with NF-κB could be degraded in response to LPS. As shown in Figure 8C , whereas the wild-type protein was degraded following 90 min of treatment with LPS/CHX (lane 4), the mutated protein remained stable (lane 9). We also tested whether the lysine at position 145 (position 6 after the second methionine) was important, since the corresponding lysine residues of IκB-α (Lys21 and Lys22) are required for degradation, but mutation of this residue had no effect (lane 14). The double mutant containing mutation of the two serines and the lysine was also stable (data not shown). we analysed the expression of IκB-ε in fibroblasts derived with 1 μg/ml LPS ϩ 10 μg/ml CHX for 120 min (lanes 2 and 5) or from mice homozygously deficient for IκB-α (Klement treated with 1 μg/ml LPS ϩ 10 μg/ml CHX for 120 min following et al., 1996) . To our surprise, we found that, unlike the pre-treatment with 100 μM ALLN for 45 min (lanes 3 and 6). The positions of IκB-ε proteins are indicated. situation found for IκB-β, IκB-ε protein levels are strongly dependent on the respective affinities of the proteins for each other. However, using in vitro co-translation followed by immunoprecipitation, we could demonstrate that IκB-ε and p52 can associate (data not shown).
IκB-ε protein levels are up-regulated in IκB-α-deficient fibroblasts

Structure of IκB-ε
Examination of the structure of the IκB-ε protein reveals it to contain many of the features of other IκB molecules. The IκB-ε protein contains six copies of the structural motif known as the ankyrin repeat found in all other members of the IκB family. It is known that IκB-β also contains six such repetitions, as does the Drosophila IκB protein Cactus. IκB-α would seem to contain only five, whereas the cytoplasmic precursors p100 and p105, as well as the nuclear IκB molecule Bcl3, contain seven. The relevance of this different number of ankyrin repeats is not clear. It may be that the number of ankyrin repeats, as well as their primary structure, is important in determining the specificity and affinity of interaction between the different IκB proteins and the numerous ( Figure 1D ). More specifically, IκB-ε contains two serine residues spaced by three amino acids that are found in a sequence context highly similar to those found in IκB-α increased in these cells (Figure 9 ). These cells do not contain any constitutively activated NF-κB complexes in and IκB-β. These two serine residues have been shown to play a critical role in the regulation of the activity of their nuclei, and other NF-κB-regulated gene products such as cRel or p105 are similarly not affected (Klement these two molecules Brown et al., 1995; Chen et al., 1995; Traenckner et al., 1995; Whiteside et al., 1996) . This suggests some sort of compensatory mechanism and cross-talk between IκB family members et al., 1995; Didonato et al., 1996; McKinsey et al., 1996) . The presence of an acidic residue N-terminal to the second (see below).
serine resembles the sequence found in IκB-α more than that of IκB-β, where a glycine residue is present. In Discussion addition, IκB-ε also contains a lysine residue situated 10 residues N-terminally to the two serine residues. In In an attempt to identify novel proteins capable of interacting with the p52 subunit of NF-κB, we have isolated the case of IκB-α, there are two lysine residues similarly situated which have been shown to be the major sites for a cDNA which encodes a protein containing six ankyrin repeats highly homologous to those found in the IκB ubiquitination following signal-induced phosphorylation, since mutation of these sites inhibits inducible degradation family of proteins. Further analysis of the protein encoded by this cDNA reveals it to be a novel IκB family member; Baldi et al., 1996) . IκB-β also contains a lysine residue similarly situated, although when overexpressed in cells, the protein can inhibit transactivation from a NF-κB-driven promoter both by whether this represents the primary site for inducible ubiquitination is less clear (R.Weil and A.Israël, unpubco-transfected rel proteins and by inducers of NF-κB activity. In addition, the overexpressed protein is capable lished data). The presence of similarly positioned serine and lysine residues in IκB-ε suggests that the signalling of retaining NF-κB proteins in the cytoplasm of transfected HeLa cells (data not shown). Since there are, to date, four events reponsible for the degradation of this protein are controlled by a mechanism similar to that for IκB-α and cytoplasmic inhibitors of NF-κB activity (IκB-α/MAD3, IκB-β, IκB-γ/the C-terminal moiety of p105 and IκB-δ/ IκB-β (see below). A further region of structural importance found in IκB-the C-terminal moiety of p100), we have called this new IκB protein IκB-ε. We have shown that, in resting cells, α and IκB-β is the C-terminal PEST domain, whose presence has been shown to be necessary for inducible IκB-ε exists as multiple, differentially phosphorylated isoforms which form complexes predominantly with RelA degradation (Brown et al., 1995; Rodriguez et al., 1995; Whiteside et al., 1995) , although conflicting data can be and cRel (Figure 4 ). This might seem contradictory with the bait used for screening (p52); however, the situation found in the recent literature (Aoki et al., 1996; Sun et al., 1996) . In IκB-α, this region is heavily phosphorylated in in yeast, where only p52 and IκB-ε are present, is clearly different from the situation in cells where all members of resting cells, probably by casein kinase II, and these phosphorylations seem to be mainly responsible for the the families are present and the actual associations are Fig. 8 . Degradation of transfected IκB-ε proteins. (A) 70Z/3 cells stably expressing the 45 kDa form of IκB-ε (amino acids 140-500) containing a 9E10 myc epitope at its N-terminus were treated as indicated and cytoplasmic extracts prepared. Lysates were precipitated with anti-RelAC and anti-mcRelC, and immune complexes were collected and separated by SDS-PAGE. Transfected IκB-ε proteins were detected by Western blotting with anti-9E10 monoclonal antibody. Cells were either untreated (lane 1), or treated with 10 ng/ml PMA ϩ 1 μg/ml CHX (lanes 2-5), 1 μg/ml LPS ϩ 1 μg/ml CHX (lanes 6-9) or 1 μg/ml CHX (lanes 10-13). (B) Cytoplasmic lysates were prepared from the same cells as in (A) treated as follows: lane 1, untreated; lanes 2-4, 1 μg/ml CHX for 90 min; lanes 5-7, 1 μg/ml LPS ϩ 1 μg/ml CHX for 90 min. Where indicated, cells were pre-treated with either 500 μM PDTC (lanes 3 and 6) or 100 μM ALLN (lanes 4 and 7) for 45 min before induction. Transfected IκB-ε proteins were detected as in (A). (C) Cytoplasmic lysates were prepared from 70Z/3 cells stably expressing either the wild-type or mutated forms of the 45 kDa form of IκB-ε containing a myc epitope at its N-terminus, and treated as follows: lanes 1, 2, 6, 7, 11 and 12, untreated; lanes 3, 8 and 13, 1 μg/ml CHX for 90 min; lanes 4, 5, 9, 10, 14 and 15, 1 μg/ml LPS ϩ 1 μg/ml CHX for 90 min. Where indicated, cells were pre-treated with 500 μM PDTC (lanes 5, 10 and 15) for 45 min before induction. Extracts were precipitated with either anti-IκBε812 (lanes 1, 6 and 11) or anti-RelAC and anti-mcRelC (remaining lanes), immune complexes collected and subjected to SDS-PAGE and transfected IκB-ε proteins were visualized by immunoblotting with anti-9E10 monoclonal antibody. Transfected IκB-ε proteins were as follows: lanes 1-5 (WT), wild-type IκB-ε amino acids 140-500; lanes 6-10 (A157A161), wild-type IκB-ε amino acids 140-500 containing mutation of serines 157 and 161 to alanines; lanes 11-15 (R145), wild-type IκB-ε amino acids 140-500 containing mutation of Lys145 to arginine. The positions of the epitope-tagged IκB-ε proteins are indicated.
turnover of the molecule in unstimulated cells (Lin et al., hyperphosphorylated forms). Closer analysis of the DNA sequence revealed the first ATG codon to lie in a sequence 1996; McElhinny et al., 1996; Schwartz et al., 1996) . Analysis of the sequence of IκB-ε shows that the region context highly unfavourable for translation, there being a pyrimidine residue at the critical -3 position (Kozak, C-terminal to the last ankyrin repeat is much shorter than those found in the other two inhibitors, and not to be 1992), whereas the second ATG codon is situated in a much more favourable context ( Figure 1B ). In addition, particularly rich in P, E, D, S or T residues. IκB-ε degradation would thus appear to be independent of a when cDNAs that initiate translation at this second ATG codon are expressed either in vitro (data not shown) or C-terminal PEST sequence (see below). Closer examination reveals this C-terminal domain to contain one casein in vivo (Figure 8 ), they give rise to a protein with a molecular weight indistinguishable from that of endogenkinase II site (IκB-α and IκB-β contain six and four respectively). Indeed, we have shown that IκB-ε is phosous IκB-ε, suggesting that translation does indeed initiate at this second ATG codon in vivo. An alternative possibility phorylated constitutively in uninduced cells, although the site(s) and nature of this phosphorylation remain to be would be that the 45 kDa protein is the result of a proteolytic processing of the 62 kDa form. Indeed, the elucidated.
The most startling difference between IκB-ε and the N-terminal region is rich in glycine residues and as such resembles the region in p105 responsible for the maturation other IκB molecules is the presence of the long N-terminal extension giving rise to an ORF of 500 amino acids and of p105 into p50 (Lin and Ghosh, 1996) . However, when the long, 62 kDa form of IκB-ε is expressed either in vitro a predicted mol. wt of 55 kDa. However, the IκB-ε protein exists in cells as a 45 kDa species (and the corresponding or in vivo from constructs in which the ATG codon has cytoplasm of unstimulated cells. It remains to be established how the various NF-κB molecules are shared out between the different IκB molecules present in the cytoplasm. An interesting possibility would be that the availability of IκB molecules might dictate which NF-κB complexes can be found in the cytoplasm.
Regulation of IκB-ε activity
As is the case for both IκB-α and IκB-β, IκB-ε activity is regulated by proteolytic degradation. Following treatment with inducers of NF-κB activity, IκB-ε is degraded with relatively slow kinetics when compared with IκB-α and thus seems to resemble IκB-β in this respect. Pre-treatment observation is confirmed by the reappearance of IκB-ε in these cells after 120 min of treatment. It would seem, therefore, that IκB-ε is sharply regulated, with the period of time been situated in a sequence context ensuring highly between degradation and resynthesis being relatively short. efficient initiation of translation, no protein at 45 kDa is For this and similar stimuli, IκB-ε could control the transient apparent (data not shown). Also, we have been unable to induction of an NF-κB activity, but with slower kinetics demonstrate the existence of a 62 kDa protein in various than those seen for IκB-α. cell types, even if cells are treated with protease inhibitors
The presence of hyperphosphorylated isoforms of IκB-ε that have been shown to block the maturation of p105 in cells may also be important for the regulation of its and p100 (data not shown). Furthermore, since we have activity, although how this might be so remains unclear, been unable to distinguish between the long, 62 kDa form since we have shown that all isoforms are associated with and the short, 45 kDa form in any assay thus far performed rel proteins and are degraded in response to the stimuli thus (interaction with NF-κB proteins, inhibition of DNA far tested. binding, cytoplasmic retention, inhibition of transactiv-
The mechanism of IκB-ε degradation would seem to ation or kinetics of degradation), it seems illogical to us be very similar to that of IκB-α: following stimulation that a precursor protein would be synthesized that has the with LPS in THP-1 cells, a slower migrating form of the exact same properties as its product. We thus prefer the protein becomes apparent ( Figure 5A , lower panel, lanes hypothesis that IκB-ε is synthesized as a 45 kDa protein 2 and 7), which is stabilized following treatment with the with translation initiating at the second ATG codon at proteasome inhibitor ALLN and subsequent inhibition of position 140 in the ORF. We cannot, however, exclude degradation ( Figure 6 and data not shown). Both these the possibility that the long 62 kDa form is expressed in results are suggestive of a mechanism similar to that some cell types or under some physiological conditions responsible for the inducible degradation of IκB-α as that we have not yet tested. discussed above. Since Ser157 and Ser161 of IκB-ε lie in a sequence context which closely resembles that found IκB-ε-associated rel proteins around Ser32 and Ser36 of IκB-α, it is tempting to When we analysed the amounts of the four ubiquitously speculate that inducible phosphorylation on these two expressed rel proteins associated with IκB-ε, we were surserines signals IκB-ε to be degraded. Indeed, mutation prised to find that IκB-ε was associated almost exclusively of these two serines to non-phosphorylatable alanines with RelA and cRel, whereas IκB-α was found in complexes abolishes IκB-ε degradation in response to LPS ( Figure  containing p50 and RelA ( Figures 4B and 7) . In most cell 8C). The presence of a lysine residue (Lys145) at a lines tested, IκB-ε was associated with as much, if not more, position similar to those in IκB-α shown to be the main RelA and cRel than either IκB-α or IκB-β. In fact, IκB-α sites for phosphorylation-induced ubiquitination (Lys21 is associated with a small percentage of the cytoplasmic and Lys22), suggests a similar mechanism for targeting RelA and cRel present, whereas IκB-β and IκB-ε were the protein for degradation. However, Lys145 does not associated with comparable and larger amounts. We thus seem to be a primary target for ubiquitination, since its believe that IκB-ε represents a major regulator of NF-κB mutation has no effect upon LPS-induced degradation activity in certain cell types and in response to certain ( Figure 8C ). Differently to IκB-α and IκB-β, IκB-ε stimuli. One exception that we have found has been the contains no PEST-like region C-terminal to the ankyrin murine pre-B cell line 70Z/3, in which almost all the RelA repeats. Deletion of this short C-terminal region renders protein is associated with IκB-β. It must be noted that these IκB-ε unstable and the truncated protein is no longer able cells contain little endogenous IκB-ε (data not shown). It to interact with rel proteins (data not shown). The absence would thus seem that in the lymphocyte cell lines tested, of a C-terminal PEST region may explain the slow kinetics IκB-β and IκB-ε represent the two major isoforms of IκB responsible for tethering cRel and RelA proteins in the of degradation of IκB-ε.
Why do multiple IκB proteins exist?
regulates a specific subset of NF-κB-responsive genesthose whose promoters are regulated by NF-κB complexes From studies upon the kinetics of degradation of IκB-α and IκB-β proteins in response to extracellular stimuli of that contain only RelA and/or cRel proteins. Future studies of the genes which are up-regulated in mice deficient for NF-κB activity, it has been proposed that the two inhibitors play a complementary role in the regulation of NF-κB IκB-β or IκB-ε will help to clarify these points. It is important to note that IκB-ε expression is up-regulated activity: IκB-α is responsible for a fast, transient activation of NF-κB, being degraded rapidly in response to extracelduring differentiation of HL-60 cells into macrophages or granulocytes (Figure 3) , suggesting an important role for lular signalling events and resynthesized shortly afterwards in a NF-κB-dependent manner. On the other hand, IκB-this protein in these cells. Another interesting observation concerning the IκB-α-β, whose gene expression does not seem to be regulated by NF-κB, is responsible for the biphasic response of NFdeficient mice is the fact that while the level of IκB-ε is undetectable in fibroblasts from wild-type mice, it is κB to certain stimuli (Thompson et al., 1995) , as well as for the regulation of slower NF-κB-controlled events strongly increased in fibroblasts from IκB-α -/-mice ( Figure 9 ). Since this increase cannot be explained by (Molitor et al., 1990) . IκB-ε would appear to share some properties of both these inhibitors: it is degraded with activation induced by constitutively nuclear NF-κB complexes, this suggests some sort of compensatory mechanslower kinetics (like IκB-β) but is also resynthesized in response to some stimuli and thus probably acts to ism, and the sustained NF-κB response observed when these fibroblasts are stimulated with TNF could be due to autoregulate NF-κB activity, as is the case for IκB-α. It seems likely, therefore, that in human cells, IκB-ε is the degradation of IκB-ε, since TNF treatment does not seem to induce IκB-β degradation in these cells (Klement responsible for controlling a third type of NF-κB response: those that are slow but still transient in nature. , although release of NF-κB from other inhibitors (e.g. p100 or p105) is also possible. question remains of how NF-κB that is liberated from IκB-ε (as well as IκB-β) with slower kinetics is not It is intriguing to speculate that the different IκB molecules may control the regulation of different genes retained by newly synthesized IκB-α. As discussed below, since IκB-ε interacts with a subset of NF-κB complexes, by binding to and inhibiting different populations of NF-κB molecules in the cytoplasm. (It may be the case that it may be that these proteins have a low affinity for IκB-α. Alternatively, it is possible that following IκB-β or further IκB molecules which regulate other subsets of NF-κB activity remain to be identified.) Such specificity of IκB-ε degradation, NF-κB is modified in such a way (e.g. phosphorylation) that it becomes inaccessible to inhibition regulation would make different IκB proteins good targets for pharmacological agents which specifically inhibit subby other IκB molecules.
IκB-ε also differs from previously identified inhibitors sets of NF-κB responses. What is clear, however, is that different cell types exhibit different 'fingerprints' of RelA in that it seems to control the regulation of a different type of NF-κB complex, those containing just RelA and/ and cRel proteins associated with the various IκB molecules ( Figure 4A ). This difference is probably important or cRel (see, for example, Ganchi et al., 1993) . Although classical NF-κB is composed of heterodimers between in determining the type of NF-κB response to occur following activation by a given stimulus and, subsequently, p50 and RelA/cRel (those recognized by IκB-α and IκB-which genes are transactivated. β), and is responsible for the regulation of many of the genes containing κB sites, there are precedents for the existence of RelA/cRel-containing complexes controlling
Materials and methods
gene expression: in the case of the IL-8 and tissue factor Yeast transformation and two-hybrid screening (TF) promoters, it has been shown that the NF-κB sites Cells were transformed using the lithium acetate method (Gietz et al., responsible for induction of these genes are unable to bind, 1992). For screening of the library, cells already transformed by the or to be transactivated by, p50/RelA NF-κB complexes pAS2/p52 plasmid (see below) were retransformed with 100 μg of library DNA (Harper et al., 1993) and double transformants were Oeth et al., 1994) . However, selected on ura -leu -trp -his -glucose plates supplemented with 25 mM 3-these sites can bind to and are transactivated by homoaminotriazole (3-AT). Five days after transformation, the surviving cells dimers or heterodimers of cRel and RelA. It has been were tested for β-galactosidase activity using a filter lift assay. Colonies shown that there exists a subset of genes inducible were transferred onto nylon filters (Amersham Hybond-N), permeabilized by freezing in liquid nitrogen and thawed at room temperature. Filters in activated macrophages and endothelial cells whose were then overlaid on Whatmann 3MM paper saturated with an X-gal promoters are controlled by NF-κB sites which only (5-bromo, 4-chloro, 3-indolyl, β-D-galactopyranoside, Sigma) solution bind RelA/cRel heterodimers in vitro (ICAM1, GM-CSF) (0.04% in Z-buffer, Breeden and Nasmyth, 1987) and incubated at room . Furthermore, studies on IκB- genes expressed in haematopoetic tissues, including GMCells CSF, is not elevated . The authors HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) explain this observation by suggesting that factors other supplemented with 10% newborn calf serum. 70Z/3, Jurkat, THP-1 and HL-60 cells were maintained in RPMI supplemented with 10% fetal than NF-κB control the expression of these genes, but it calf serum (FCS) and 50 μM β-mercaptoethanol. HL-60 cells were is equally likely that other IκB molecules are responsible. differentiated into monocytes or into granulocytes as described in the It is interesting to note that the expression of these genes legend to Figure 3 . 70Z/3 cells stably expressing forms of IκB-ε were is activated in cell lines which contain large amounts of obtained as described in Whiteside et al. (1995) , using plasmids cDNA3βIκB-ε62kNT or cDNA3βIκB-ε45kNT linearized with PvuI.
IκB-ε (e.g. macrophages, T cells, B cells, but not pre-B cells nor fibroblasts; S.T. Whiteside and A.Israël, in Antisera preparation). Thus in addition to controlling slow, transient
Of the antisera used, the following have already been described (Rice et al., 1992; Whiteside et al., 1995; Klement et al., 1996) : anti-p50, responses, we propose a model in which IκB-ε also 105N (1141) and anti-p50 (#3); anti-p52, 100N (1267); anti-RelA, Transfections RelAN (1207) and RelAC (1226); anti-cRel, cRelC (265); mcRelC 293T cells were transfected by calcium phosphate precipitation and (1051); anti-IκB-α, IκBαN (1309) and anti-mIκBα (751).
extracts prepared 2 days following transfection. HeLa cells were Anti-IκB-ε: IκBε812 and IκBε891, were raised against amino acids transfected with Lipofectamine (Gibco BRL) according to the manufac-225-240 and 191-211 respectively of the human IκB-ε protein. The turer's instructions and prepared for indirect immunofluorescence 2 days anti-IκB-α antiserum S5 (IκBαS5), a gift of R.T.Hay (St Andrews, UK), after transfection. Jurkat cells were transfected by DEAE-dextran. was raised against recombinant human IκB-α. The anti-IκB-β antisera, Briefly, 2 μg of DNA were placed into the well of a 96-well tissue raised against recombinant murine IκB-β, were a kind gift of R.Weil culture dish; to this were added 2ϫ10 6 cells in 100 μl of Tris-buffered (Biologie Moléculaire de l'Expression Génique, Institut Pasteur).
saline and 100 μl of 1 mg/ml DEAE-dextran (Pharmacia). After 45 min at room temperature, cells were collected by centrifugation and transPlasmids ferred into 2 ml of RPMI/10% FCS in 24-well plates. Cells were Plasmid pAS2/p52 was constructed by cloning p52 between the BamHI harvested the following day and lysed in 100 μl of luciferase buffer (25 and XhoI sites of pAS2 (Durfee et al., 1993) . The human lymphocyte mM Tris-phosphate pH 7.8, 8 mM MgCl 2 , 1 mM dithiothreitol, 1% cDNA library (Durfee et al., 1993) and plasmid pAS2 were kind gifts Triton X-100, 15% glycerol). Luciferase activity was quantified using a from Dr S.Elledge (Baylor College, TX).
Berthold luminometer. cDNA clones isolated from λZAP library screenings were excised in vivo using R408 helper phage. A full-length IκB-ε clone was Immunoblots constructed by fusing two overlapping cDNAs at the unique BspHI site Proteins were transferred onto Immobilon (Millipore) and filters were situated at residue 260 and then cloned into pBluescriptSK (Stratagene).
blocked in PBS supplemented with 5% skimmed milk (Regilait). Immuno-IκB-ε-coding sequences from amino acids 1-500 or 140-500 were blots were incubated with sera diluted 1:1000 in PBS/5% milk/0.1% amplified by PCR and cloned into pT7βplink or pT7βplinkTAG and revealed either with the Amersham ECL system, or by and Treisman, 1990) . Cassettes containing the β-globin 5Ј-untranslated incubation in [ 125 I]proteinA (Amersham) diluted in PBS/5% milk/0.1% region and IκB-ε-coding sequences subsequently were transferred into Tween-20 and subsequent autoradiography. pcDNA3 (InVitrogen) using HindIII and XbaI to construct cDNA3βIκ B-ε62k and cDNA3βIκB-ε45k (for use in transfection studies, Figure 2 ) and their 9E10-tagged counterparts cDNA3βIκB-ε62kNT and cDNA3βIκ B-ε45kNT (used in establishing stable lines, Figures 7 and 8) . Mutants
